GIVEN BRUCE D
Insider CIK 1219384 · ARWR Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-04-28 | 2020-04-29 | 500 | — | $0 | 333,044 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-04-28 | 2020-04-29 | 1,454 | — | $0 | 331,590 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-04-28 | 2020-04-29 | 1,200 | — | $0 | 330,390 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-04-28 | 2020-04-29 | 830 | — | $0 | 329,560 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-04-28 | 2020-04-29 | 213 | — | $0 | 329,347 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-04-28 | 2020-04-29 | 213 | $5.20 | $1.1K | 855,831 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-04-28 | 2020-04-29 | 1,454 | $14.54 | $21.1K | 853,588 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-04-28 | 2020-04-29 | 500 | $40.00 | $20.0K | 855,331 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-04-28 | 2020-04-29 | 1,454 | $40.00 | $58.2K | 853,877 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-04-28 | 2020-04-29 | 1,200 | $40.00 | $48.0K | 852,677 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-04-28 | 2020-04-29 | 830 | $40.00 | $33.2K | 851,847 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-04-28 | 2020-04-29 | 213 | $40.00 | $8.5K | 851,634 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-04-28 | 2020-04-29 | 204 | $40.00 | $8.2K | 851,430 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-04-28 | 2020-04-29 | 700 | $40.00 | $28.0K | 850,730 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-04-28 | 2020-04-29 | 830 | $5.19 | $4.3K | 855,618 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-04-28 | 2020-04-29 | 500 | $7.75 | $3.9K | 852,134 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-04-28 | 2020-04-29 | 1,200 | $4.75 | $5.7K | 854,788 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-04-27 | 2020-04-29 | 200 | — | $0 | 333,544 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-04-27 | 2020-04-29 | 100 | $40.00 | $4.0K | 851,634 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-04-27 | 2020-04-29 | 200 | $40.00 | $8.0K | 851,734 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-04-27 | 2020-04-29 | 200 | $5.19 | $1.0K | 851,934 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-04-20 | 2020-04-22 | 5,300 | — | $0 | 333,744 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-04-20 | 2020-04-22 | 3,800 | — | $0 | 346,200 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-04-20 | 2020-04-22 | 3,700 | — | $0 | 342,500 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-04-20 | 2020-04-22 | 3,456 | — | $0 | 339,044 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-04-20 | 2020-04-22 | 3,454 | $40.00 | $138.2K | 855,539 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-04-20 | 2020-04-22 | 3,700 | $40.00 | $148.0K | 867,749 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-04-20 | 2020-04-22 | 3,800 | $40.00 | $152.0K | 871,449 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-04-20 | 2020-04-22 | 3,456 | $40.00 | $138.2K | 864,293 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-04-20 | 2020-04-22 | 3,800 | $4.75 | $18.1K | 862,793 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-04-20 | 2020-04-22 | 3,700 | $5.19 | $19.2K | 866,493 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-04-20 | 2020-04-22 | 5,300 | $40.00 | $212.0K | 858,993 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-04-20 | 2020-04-22 | 3,805 | $40.00 | $152.2K | 851,734 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-04-20 | 2020-04-22 | 3,456 | $5.20 | $18.0K | 869,949 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-04-20 | 2020-04-22 | 5,300 | $14.54 | $77.1K | 875,249 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-01-06 | 2020-01-08 | 1,300 | $60.99 | $79.3K | 858,993 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-01-06 | 2020-01-08 | 22,466 | $60.37 | $1.36M | 860,293 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-01-06 | 2020-01-08 | 11,847 | $59.57 | $705.7K | 882,759 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2020-01-01 | 2020-01-03 | 250,000 | — | $0 | 894,606 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-03-01 | 2019-03-01 | 42,500 | — | $0 | 350,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-03-01 | 2019-03-01 | 42,500 | $2.01 | $85.4K | 687,106 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-03-01 | 2019-03-01 | 42,500 | $19.99 | $849.6K | 644,606 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-02-25 | 2019-02-27 | 42,500 | — | $0 | 392,500 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-02-25 | 2019-02-27 | 42,500 | $2.01 | $85.4K | 687,106 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-02-25 | 2019-02-27 | 42,500 | $18.98 | $806.6K | 644,606 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-02-19 | 2019-02-20 | 42,500 | — | $0 | 435,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-02-19 | 2019-02-20 | 42,500 | $2.01 | $85.4K | 687,106 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-02-19 | 2019-02-20 | 42,500 | $17.98 | $764.1K | 644,606 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-02-15 | 2019-02-20 | 26,250 | $17.67 | $463.8K | 644,606 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-02-12 | 2019-02-12 | 42,500 | — | $0 | 477,500 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-02-12 | 2019-02-12 | 42,500 | $17.06 | $725.0K | 670,856 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-02-12 | 2019-02-12 | 42,500 | $2.01 | $85.4K | 713,356 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-02-11 | 2019-02-12 | 11,667 | — | $0 | 520,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-02-11 | 2019-02-12 | 57,000 | $16.48 | $939.4K | 670,856 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-02-11 | 2019-02-12 | 97,167 | $15.66 | $1.52M | 727,856 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-02-11 | 2019-02-12 | 11,667 | $2.62 | $30.6K | 825,023 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-02-08 | 2019-02-12 | 11,667 | — | $0 | 531,667 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-02-08 | 2019-02-12 | 46,167 | $15.34 | $708.2K | 813,356 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-02-08 | 2019-02-12 | 11,667 | $2.62 | $30.6K | 859,523 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-02-05 | 2019-02-07 | 22,500 | $14.48 | $325.8K | 847,856 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-02-01 | 2019-02-01 | 28,500 | $13.85 | $394.7K | 870,356 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-01-23 | 2019-01-24 | 17,500 | $13.15 | $230.1K | 898,856 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-01-22 | 2019-01-24 | 152,000 | $13.59 | $2.07M | 916,356 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-01-14 | 2019-01-16 | 1,000 | — | $0 | 543,334 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2019-01-14 | 2019-01-16 | 11,666 | — | $0 | 544,334 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-01-14 | 2019-01-16 | 42,666 | $14.40 | $614.4K | 1,068,356 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-01-14 | 2019-01-16 | 11,666 | $2.62 | $30.6K | 1,110,022 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2019-01-14 | 2019-01-16 | 1,000 | $6.20 | $6.2K | 1,111,022 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-01-02 | 2019-01-03 | 20,000 | $11.98 | $239.6K | 1,098,356 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2019-01-01 | 2019-01-03 | 210,000 | — | $0 | 1,118,356 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2018-03-05 | 2018-03-05 | 20,000 | $6.73 | $134.6K | 908,356 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2018-01-01 | 2018-01-03 | 175,000 | — | $0 | 948,356 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2018-01-01 | 2018-01-03 | 20,000 | $3.69 | $73.8K | 928,356 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2017-01-01 | 2017-01-04 | 380,000 | — | $0 | 773,356 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | F Tax w/h | 2016-03-04 | 2016-03-08 | 13,675 | $4.33 | $59.2K | 393,356 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | F Tax w/h | 2016-02-06 | 2016-02-09 | 17,969 | $3.46 | $62.2K | 407,031 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2016-01-01 | 2016-01-04 | 60,000 | — | $0 | 556,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award | 2016-01-01 | 2016-01-04 | 150,000 | — | $0 | 425,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2015-03-06 | 2015-03-06 | 60,000 | — | $0 | 496,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award | 2015-03-04 | 2015-03-06 | 150,000 | — | $0 | 275,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2014-02-06 | 2014-02-10 | 50,000 | — | $0 | 436,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award | 2014-02-06 | 2014-02-10 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2013-09-21 | 2013-09-24 | 40,000 | — | $0 | 386,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2013-05-06 | 2013-05-08 | 170,000 | — | $0 | 346,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2012-09-28 | 2012-10-02 | 35,000 | — | $0 | 176,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2012-02-16 | 2012-07-09 | 110,000 | — | $0 | 141,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2012-02-16 | 2012-02-21 | 110,000 | — | $0 | 141,000 | SEC↗ |